Narrative review / 2021
NAD+ levels decline with age across several organisms, and restoring levels is being explored to address age-related metabolic and cognitive decline.
This review examines how ageing impacts NAD+ metabolism and describes strategies to counter its age-dependent decline. NAD+ serves as a vital coenzyme and signalling molecule consumed by enzymes like PARPs, SARM1, sirtuins, and CD38. Tissue NAD+ levels decrease during ageing due to an imbalance between synthesis and consumption, and this decline has been linked to metabolic diseases and cognitive decline. Therapeutic augmentation of NAD+ levels may halt or reverse the progression of certain age-related conditions.
- Study type
- Narrative review
- Who was studied
- Humans and other organisms (ageing context)
- What was measured
- NAD+ biosynthesis, consumption, and age-related diseases
THE PAPER
The balance between NAD+ biosynthesis and consumption in ageing.
Strømland Ø, Diab J, Ferrario E, Sverkeli LJ, Ziegler M. Mech Ageing Dev, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.